HL-032

· HanAll BioPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HL-032, covering 2012-10-16 to 2012-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers [Phase 1]